Loading...
| A03282 | Pages: 189 | Nov 2021 | 9905 Views | | |
| Author(s) : Swapna Singh , Onkar Sumant | Tables: 115 | Charts: 06 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Coated Endotracheal Tube Market
Request Now !Global coated endotracheal tube market was valued at $126.13 million in 2020, and is projected to reach $237.99 million by 2030, growing at a CAGR of 6.5% from 2021 to 2030.
The coated endotracheal tube market is expected to be positively impacted by the COVID-19 pandemic. As endotracheal tube has extensively been used for ventilation during pandemic. Tracheal intubation in COVID patients poses a unique set of challenges. It combines complex time-critical tasks in physiologically difficult airways. Moreover, providing best practices regarding intubation and ventilation for an overwhelming number of patients with COVID-19 amid an enhanced risk of cross-infection is a daunting undertaking.
Endotracheal tube is a medical device, which is used to provide artificial airway. It is placed when a patients are unable to breathe on their own. It is inserted through the mouth or nose into the trachea (windpipe) to help a patient breathe during surgery. Coated endotracheal tube is a specific tube coated with antithrombotic agents to prevent biofilm. Coating reduces the ventilator associated pneumonia (VAP) incidence by preventing bacterial colonization and biofilm formation. The major factor that contributes to the growth of the coated endotracheal tube market includes rise in number of surgical procedures due to increase in prevalence of chronic respiratory diseases such as cardiovascular diseases, respiratory diseases, diabetes, cancer, and other lung injuries. Moreover, increase in incidence of ventilator-associated pneumonia, rise in awareness about technologically advanced endotracheal tube, and developments in the field of nanobiotechnology & drug design are the key factors projected to drive the growth of the global coated endotracheal tubes market. However, dearth of skilled professionals and post-operative risks associated with laparoscopy surgeries hamper the market growth. Conversely, developing economies provide lucrative growth opportunities for the market, due to surge in geriatric population, advanced healthcare infrastructure, and high surge in patients with VAP.
Get more information on this report : Request Sample Pages
The global coated endotracheal tube market is segmented into intubation, application, end user, and region. Depending on intubation, the market is bifurcated into orotracheal intubation and nasotracheal intubation.
The applications covered in the study include anesthesia, emergency medicine, and others. On the basis of end user, the market is classified into hospital, clinics, and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Coronavirus (COVID-19) was discovered in December 2019 in Hubei province of Wuhan city in China. The disease is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans.
After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population. On March 11, 2020, the World Health Organization made an assessment that COVID-19 can be characterized as pandemic. In addition, only a few vaccines that received emergency approvals for COVID-19 prevention. Thus, social distancing is observed as the most important measure to stop the spread of this disease. Furthermore, to maintain social distancing, various countries across the world have adopted nationwide lockdowns.
Almost every nation is dealing with the outbreak. Most markets are experiencing a decline, owing to the outbreak. The COVID-19 pandemic is an unprecedented global public health challenge, and is anticipated to have a positive impact on the coated endotracheal tube market. Tracheal intubation in COVID patients poses a unique set of challenges. It combines complex time-critical tasks in physiologically difficult airways. According to the American Society of Anesthesiologists, the COVID-19 outbreak has led to 80,409 diagnosed cases and 3,012 deaths in mainland China based on the data released on March 4, 2020. Approximately 3.2% of patients with COVID-19 required intubation and invasive ventilation at some point in the disease course. Moreover, providing best practices regarding intubation and ventilation for an overwhelming number of patients with COVID-19 amid an enhanced risk of cross-infection is a daunting undertaking.
Depending on intubation, the market is divided into orotracheal intubation and nasotracheal intubation. The orotracheal intubation segment accounted for the majority of market share of the global market in 2020, owing to increase in surgical procedures due to rise in prevalence of chronic respiratory diseases, surge in cases of ventilator-associated pneumonia, and increase in incidence of genetic disorders.
Get more information on this report : Request Sample Pages
Based on coated endotracheal tube market trends by application, the market is segmented into anesthesia, emergency medicine, and others. Anesthesia segment accounted for the majority of market share of the global market in 2020 and expected to remain dominant during the forecast period, owing to rise in chronic respiratory diseases such as cardiovascular diseases, respiratory diseases, diabetes, cancer, and other lung injuries. These are the factors which is boosting the market growth.
Get more information on this report : Request Sample Pages
Based on end user, the market is segmented into hospitals, clinics, and ambulatory surgical centers. The hospital segment accounted for maximum market revenue in 2020 and is anticipated to maintain its dominant position during the forecast period. This is attributed to increase in advancement of coated endotracheal tube, increase in incidence of ventilator-associated pneumonia, awareness about technologically advanced endotracheal tube, and developments in the field of nanobio application and drug design are the key factors projected to drive the global coated endotracheal tubes market.
Get more information on this report : Request Sample Pages
Based on region, the coated endotracheal tube market is analyzed across North America, Asia-Pacific, Europe and LAMEA. North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to the increasing case of pulmonary conditions, pneumonia, cancer, and other conditions, thus rise in demand for coated endotracheal tube in such diseases are a major factor that contributes toward the growth of the coated endotracheal tube market. However, as per coated endotracheal tube market forecast, Asia-Pacific is projected to register the highest growth rate from 2021 to 2030.
Get more information on this report : Request Sample Pages
This report provides comprehensive competitive analysis and profiles of prominent market players such as Bactiguard Holding AB, Avanos Medical, Hospiteknik Healthcare, Smiths Medical Plc., Fuji Systems Corp., N8 Medical LLC, Sharklet Technologies, Inc., Medtronic, Teleflex Incorporated and Venner Medical.
Key Benefits For Stakeholders
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.SECONDARY RESEARCH
1.4.2.PRIMARY RESEARCH
1.4.3.ANALYST TOOLS & MODELS
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.TOP INVESTMENT POCKETS
3.2.2.TOP WINNING STRATEGIES
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.DRIVERS
3.5.1.1.Rise in number of surgical procedures across the globe
3.5.1.2.Presence of large pool of geriatric population and related rise in chronic diseases
3.5.1.3.Advantages of coated endotracheal tubes
3.5.2.RESTRAINTS
3.5.2.1.Dearth of skilled professionals
3.5.2.2.Post-operative risks associated with laparoscopy surgeries
3.5.3.OPPORTUNITY
3.5.3.1.High growth potential in emerging economies
3.6.COVID-19 impact analysis on the coated endotracheal tube market
CHAPTER 4:COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION
4.1.Overview
4.1.1.MARKET SIZE AND FORECAST, BY INTUBATION
4.1.Orotracheal intubation
4.1.1.KEY MARKET TRENDS, GROWTH FACTORS, AND OPPORTUNITIES
4.1.2.MARKET SIZE AND FORECAST
4.1.3.MARKET ANALYSIS, BY COUNTRY
4.1.Nasotracheal intubation
4.1.1.KEY MARKET TRENDS, GROWTH FACTORS, AND OPPORTUNITIES
4.1.2.MARKET SIZE AND FORECAST
4.1.3.MARKET ANALYSIS, BY COUNTRY
CHAPTER 5:COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION
5.1.Overview
5.1.1.MARKET SIZE AND FORECAST, BY APPLICATION
5.2.Anesthesia
5.2.1.MARKET SIZE AND FORECAST
5.2.2.MARKET ANALYSIS, BY COUNTRY
5.3.Emergency medicine
5.3.1.MARKET SIZE AND FORECAST
5.3.2.MARKET ANALYSIS, BY COUNTRY
5.4.Other applications
5.4.1.MARKET SIZE AND FORECAST
5.4.2.MARKET ANALYSIS, BY COUNTRY
CHAPTER 6:COATED ENDOTRACHEAL TUBE MARKET, BY END USER
6.1.Overview
6.1.1.MARKET SIZE AND FORECAST, BY APPLICATION
6.2.Hospitals
6.2.1.MARKET SIZE AND FORECAST
6.2.2.MARKET ANALYSIS, BY COUNTRY
6.3.Clinics
6.3.1.MARKET SIZE AND FORECAST
6.3.2.MARKET ANALYSIS, BY COUNTRY
6.1.Ambulatory surgical centers (ASCs)
6.1.1.MARKET SIZE AND FORECAST
6.1.2.MARKET ANALYSIS, BY COUNTRY
CHAPTER 7:COATED ENDOTRACHEAL TUBE MARKET, BY REGION
7.1.Overview
7.1.1.MARKET SIZE AND FORECAST, BY REGION
7.2.North America
7.2.1.KEY TRENDS AND GROWTH OPPORTUNITIES
7.2.2.MARKET SIZE AND FORECAST, BY INTUBATION
7.2.3.MARKET SIZE AND FORECAST, BY APPLICATION
7.2.4.MARKET SIZE AND FORECAST, BY END USER
7.2.5.MARKET SIZE AND FORECAST, BY COUNTRY
7.2.5.1.U.S.
7.2.5.2.U.S. market size and forecast, by intubation
7.2.5.3.U.S. market size and forecast, by application
7.2.5.4.U.S. market size and forecast, by end user
7.2.5.5.Canada
7.2.5.6.Canada market size and forecast, by intubation
7.2.5.7.Canada market size and forecast, by application
7.2.5.8.Canada market size and forecast, by end user
7.2.5.9.Mexico
7.2.5.10.Mexico market size and forecast, by intubation
7.2.5.11.Mexico market size and forecast, by application
7.2.5.12.Mexico market size and forecast, by end user
7.3.Europe
7.3.1.KEY TRENDS AND GROWTH OPPORTUNITIES
7.3.2.MARKET SIZE AND FORECAST, BY INTUBATION
7.3.3.MARKET SIZE AND FORECAST, BY APPLICATION
7.3.4.MARKET SIZE AND FORECAST, BY END USER
7.3.5.MARKET SIZE AND FORECAST, BY COUNTRY
7.3.5.1.Germany
7.3.5.2.Germany market size and forecast, by intubation
7.3.5.3.Germany market size and forecast, by application
7.3.5.4.Germany market size and forecast, by end user
7.3.5.5.France
7.3.5.6.France market size and forecast, by intubation
7.3.5.7.France market size and forecast, by application
7.3.5.8.France market size and forecast, by end user
7.3.5.9.UK
7.3.5.10.UK market size and forecast, by intubation
7.3.5.11.UK market size and forecast, by application
7.3.5.12.UK market size and forecast, by end user
7.3.5.13.Italy
7.3.5.14.Italy market size and forecast, by intubation
7.3.5.15.Italy market size and forecast, by application
7.3.5.16.Italy market size and forecast, by end user
7.3.5.17.Spain
7.3.5.18.Spain market size and forecast, by intubation
7.3.5.19.Spain market size and forecast, by application
7.3.5.20.Spain market size and forecast, by end user
7.3.5.21.Rest of Europe
7.3.5.22.Rest of Europe market size and forecast, by intubation
7.3.5.23.Rest of Europe market size and forecast, by application
7.3.5.24.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.KEY TRENDS AND GROWTH OPPORTUNITIES
7.4.2.MARKET SIZE AND FORECAST, BY INTUBATION
7.4.3.MARKET SIZE AND FORECAST, BY APPLICATION
7.4.4.MARKET SIZE AND FORECAST, BY END USER
7.4.5.MARKET SIZE AND FORECAST, BY COUNTRY
7.4.5.1.Japan
7.4.5.2.Japan market size and forecast, by intubation
7.4.5.3.Japan market size and forecast, by application
7.4.5.4.Japan market size and forecast, by end user
7.4.5.5.China
7.4.5.6.China market size and forecast, by intubation
7.4.5.7.China market size and forecast, by application
7.4.5.8.China market size and forecast, by end user
7.4.5.9.India
7.4.5.10.India market size and forecast, by intubation
7.4.5.11.India market size and forecast, by application
7.4.5.12.India market size and forecast, by end user
7.4.5.13.Australia
7.4.5.14.Australia market size and forecast, by intubation
7.4.5.15.Australia market size and forecast, by application
7.4.5.16.Australia market size and forecast, by end user
7.4.5.17.South Korea
7.4.5.18.South Korea market size and forecast, by intubation
7.4.5.19.South Korea market size and forecast, by application
7.4.5.20.South Korea market size and forecast, by end user
7.4.5.21.Rest of Asia-Pacific
7.4.5.22.Rest of Asia-Pacific market size and forecast, by intubation
7.4.5.23.Rest of Asia-Pacific market size and forecast, by application
7.4.5.24.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.KEY TRENDS AND OPPORTUNITIES
7.5.2.MARKET SIZE AND FORECAST, BY INTUBATION
7.5.3.MARKET SIZE AND FORECAST, BY APPLICATION
7.5.4.MARKET SIZE AND FORECAST, BY END USER
7.5.5.MARKET SIZE AND FORECAST, BY COUNTRY
7.5.5.1.Brazil
7.5.5.2.Brazil market size and forecast, by intubation
7.5.5.3.Brazil market size and forecast, by application
7.5.5.4.Brazil market size and forecast, by end user
7.5.5.5.Saudi Arabia
7.5.5.6.Saudi Arabia market size and forecast, by intubation
7.5.5.7.Saudi Arabia market size and forecast, by application
7.5.5.8.Saudi Arabia market size and forecast, by end user
7.5.5.9.South Africa
7.5.5.10.South Africa market size and forecast, by intubation
7.5.5.11.South Africa market size and forecast, by application
7.5.5.12.South Africa market size and forecast, by end user
7.5.5.13.Rest of LAMEA
7.5.5.14.Rest of LAMEA market size and forecast, by intubation
7.5.5.15.Rest of LAMEA market size and forecast, by application
7.5.5.16.Rest of LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.Bactiguard Holding AB
8.1.1.COMPANY OVERVIEW
8.1.2.COMPANY SNAPSHOT
8.1.3.OPERATING BUSINESS SEGMENTS
8.1.4.PRODUCT PORTFOLIO
8.1.5.BUSINESS PERFORMANCE
8.2.Avanos Medical Inc.
8.2.1.COMPANY OVERVIEW
8.2.2.COMPANY SNAPSHOT
8.2.3.OPERATING BUSINESS SEGMENTS
8.2.4.PRODUCT PORTFOLIO
8.2.5.BUSINESS PERFORMANCE
8.3.Smiths Medical Plc.
8.3.1.COMPANY OVERVIEW
8.3.2.COMPANY SNAPSHOT
8.3.3.OPERATING BUSINESS SEGMENTS
8.3.4.PRODUCT PORTFOLIO
8.3.5.BUSINESS PERFORMANCE
8.4.Hospiteknik Healthcare
8.4.1.COMPANY OVERVIEW
8.4.2.COMPANY SNAPSHOT
8.4.3.OPERATING PRODUCT SEGMENTS
8.4.4.PRODUCT PORTFOLIO
8.5.MEDTRONIC PLC. (COVIDIEN)
8.5.1.COMPANY OVERVIEW
8.5.2.COMPANY SNAPSHOT
8.5.3.OPERATING BUSINESS SEGMENTS
8.5.4.PRODUCT PORTFOLIO
8.5.5.BUSINESS PERFORMANCE
8.6.N8 Medical, LLC
8.6.1.COMPANY OVERVIEW
8.6.2.COMPANY SNAPSHOT
8.6.3.OPERATING PRODUCT SEGMENTS
8.6.4.PRODUCT PORTFOLIO
8.6.5.KEY STRATEGIC MOVES AND DEVELOPMENTS
8.7.Sharklet Technologies, Inc.
8.7.1.COMPANY OVERVIEW
8.7.2.COMPANY SNAPSHOT
8.7.3.OPERATING PRODUCT SEGMENTS
8.7.4.PRODUCT PORTFOLIO
8.8.Fuji Systems Corporation
8.8.1.COMPANY OVERVIEW
8.8.2.COMPANY SNAPSHOT
8.8.3.OPERATING PRODUCT SEGMENTS
8.8.4.PRODUCT PORTFOLIO
8.9.Teleflex Incorporated
8.9.1.COMPANY OVERVIEW
8.9.2.COMPANY SNAPSHOT
8.9.3.OPERATING BUSINESS SEGMENTS
8.9.4.PRODUCT PORTFOLIO
8.9.5.BUSINESS PERFORMANCE
8.9.6.KEY STRATEGIC MOVES AND DEVELOPMENTS
8.10.Venner Medical GmbH
8.10.1.COMPANY OVERVIEW
8.10.2.COMPANY SNAPSHOT
8.10.3.OPERATING PRODUCT SEGMENTS
8.10.4.PRODUCT PORTFOLIO
LIST OF TABLES
TABLE 01.COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030($MILLION)
TABLE 02.COATED ENDOTRACHEAL TUBE MARKET FOR OROTRACHEAL INTUBATION, BY REGION, 2020–2030($MILLION)
TABLE 03.COATED ENDOTRACHEAL TUBE MARKET FOR NASOTRACHEAL INTUBATION, BY REGION, 2020–2030 ($MILLION)
TABLE 04.COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 05.COATED ENDOTRACHEAL TUBE MARKET FOR ANESTHESIA, BY REGION, 2020–2030($MILLION)
TABLE 06.COATED ENDOTRACHEAL TUBE MARKET FOR EMERGENCY MEDICINE, BY REGION, 2020–2030 ($MILLION)
TABLE 07.COATED ENDOTRACHEAL TUBE MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2030 ($MILLION)
TABLE 08.COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 09.COATED ENDOTRACHEAL TUBE MARKET FOR HOSPITALS, BY REGION, 2020–2030($MILLION)
TABLE 10.COATED ENDOTRACHEAL TUBE MARKET FOR CLINICS, BY REGION, 2020–2030 ($MILLION)
TABLE 11.COATED ENDOTRACHEAL TUBE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 12.COATED ENDOTRACHEAL TUBE MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 13.NORTH AMERICA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 14.NORTH AMERICA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 15.NORTH AMERICA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 16.NORTH AMERICA COATED ENDOTRACHEAL TUBE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 17.U.S. COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 18.U.S. COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 19.U.S. COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 20.CANADA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 21.CANADA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 22.CANADA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 23.MEXICO COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 24.MEXICO COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 25.MEXICO COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 26.EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 27.EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 28.EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 29.EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 30.GERMANY COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 31.GERMANY COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 32.GERMANY COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 33.FRANCE COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 34.FRANCE COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 35.FRANCE COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 36.UK COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 37.UK COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 38.UK COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 39.ITALY COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 40.ITALY COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 41.ITALY COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 42.SPAIN COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 43.SPAIN COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 44.SPAIN COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 45.REST OF EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 46.REST OF EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 47.REST OF EUROPE COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 48.ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 49.ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 50.ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 51.ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 52.JAPAN COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 53.JAPAN COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 54.JAPAN COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 55.CHINA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 56.CHINA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 57.CHINA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 58.INDIA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 59.INDIA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 60.INDIA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 61.AUSTRALIA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 62.AUSTRALIA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 63.AUSTRALIA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 64.SOUTH KOREA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 65.SOUTH KOREA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 66.SOUTH KOREA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 70.LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 71.LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 72.LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 73.LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 74.BRAZIL COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 75.BRAZIL COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 76.BRAZIL COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 77.SAUDI ARABIA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 78.SAUDI ARABIA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 79.SAUDI ARABIA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 80.SOUTH AFRICA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 81.SOUTH AFRICA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 82.SOUTH AFRICA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 83.REST OF LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY INTUBATION, 2020–2030 ($MILLION)
TABLE 84.REST OF LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 85.REST OF LAMEA COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 86.BACTIGUARD: COMPANY SNAPSHOT
TABLE 87.BACTIGUARD: OPERATING SEGMENTS
TABLE 88.BACTIGUARD: PRODUCT PORTFOLIO
TABLE 89.AVANOS: COMPANY SNAPSHOT
TABLE 90.AVANOS: OPERATING SEGMENTS
TABLE 91.AVANOS: PRODUCT PORTFOLIO
TABLE 92.SMITHS MEDICAL: COMPANY SNAPSHOT
TABLE 93.SMITHS MEDICAL: OPERATING SEGMENTS
TABLE 94.SMITHS MEDICAL: PRODUCT PORTFOLIO
TABLE 95.HOSPITEK HEALTHCARE: COMPANY SNAPSHOT
TABLE 96.HOSPITEK HEALTHCARE: PRODUCT SEGMENTS
TABLE 97.HOSPITEK HEALTHCARE: PRODUCT PORTFOLIO
TABLE 01.MEDTRONIC: COMPANY SNAPSHOT
TABLE 02.MEDTRONIC: OPERATING BUSINESS SEGMENTS
TABLE 03.MEDTRONIC: PRODUCTS PORTFOLIO
TABLE 04.N8 MEDICAL LLC: COMPANY SNAPSHOT
TABLE 05.N8 MEDICAL LLC: PRODUCT SEGMENTS
TABLE 06.N8 MEDICAL: PRODUCTS PORTFOLIO
TABLE 07.SHARKLET TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 08.SHARKLET TECHNOLOGIES: PRODUCT SEGMENTS
TABLE 09.SHARKLET TECHNOLOGIES: PRODUCTS PORTFOLIO
TABLE 10.FUJI SYSTEMS: COMPANY SNAPSHOT
TABLE 11.FUJI SYSTEMS: PRODUCT SEGMENTS
TABLE 12.FUJI SYSTEMS: PRODUCTS PORTFOLIO
TABLE 13.TELEFLEX: COMPANY SNAPSHOT
TABLE 14.TELEFLEX: OPERATING SEGMENTS
TABLE 15.TELEFLEX: PRODUCT PORTFOLIO
TABLE 16.VENNER MEDICAL: COMPANY SNAPSHOT
TABLE 17.VENNER MEDICAL: PRODUCT SEGMENTS
TABLE 18.VENNER MEDICAL: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.TOP INVESTMENT POCKETS
FIGURE 02.TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2017–2019(%)
FIGURE 03.TOP WINNING STRATEGIES: BY DEVELOPMENT, 2017-2019(%)
FIGURE 04.TOP WINNING STRATEGIES: BY COMPANY, 2017–2019 (%)
FIGURE 05.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE THREAT OF SUBSTITUTES
FIGURE 08.MODERATE THREAT OF NEW ENTRANTS
FIGURE 09.HIGH INTENSITY OF RIVALRY
FIGURE 10.TOP PLAYER POSITIONING, 2020
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR OROTRACHEAL INTUBATION BY COUNTRY, 2020 & 2030 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR NASOTRACHEAL INTUBATION BY COUNTRY, 2020 & 2030 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR ANESTHESIA BY COUNTRY, 2020 & 2030 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR EMERGENCY MEDICINE BY COUNTRY, 2020 & 2030 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR OTHER APPLICATIONS BY COUNTRY, 2020 & 2030 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR HOSPITALS BY COUNTRY, 2020 & 2030 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR CLINICS BY COUNTRY, 2020 & 2030 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF COATED ENDOTRACHEAL TUBE MARKET FOR AMBULATORY SURGICAL CENTERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 19.BACTIGUARD: NET SALES, 2018–2020 ($MILLION)
FIGURE 20.AVANOS: NET SALES, 2018–2020 ($MILLION)
FIGURE 21.AVANOS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 22.AVANOS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 23.SMITHS MEDICAL: NET SALES, 2018–2020 ($MILLION)
FIGURE 24.
FIGURE 25.SMITHS MEDICAL: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26.SMITHS MEDICAL: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 01.MEDTRONIC: NET SALES, 2018–2020 ($MILLION
FIGURE 02.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 03.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 04.TELEFLEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 05.TELEFLEX: REVENUE SHARE BY BUSINESS SEGMENT, 2020 (%)
FIGURE 06.TELEFLEX: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
This section provides opinions of the CXOs of key companies operating in the coated endotracheal tubes industry. According to the CXOs, the adoption of endotracheal tubes is expected to increase due to rise in prevenance of various types of chronic diseases such as cardiovascular disorders and diabetes. These tubes provide proper airway management during surgical procedures and prevent the airway obstruction.
As per the CXOs, upsurge in cases of chronic diseases and increase in prevalence of diabetes make it imperative to use endotracheal tubes during intubation processes or surgeries. Moreover, increase in prevalence of ventilator associated pneumonia, advantages of coated endotracheal tubes with lesser side effects, rise in geriatric population, and surge in affordability in developing economies are projected to supplement the market growth. However, complications associated with these tubes and dearth of skilled professionals are expected to impede the market growth.
The CXOs further added that the use of coated endotracheal tubes is highest in North America, owing to increased usage of endotracheal intubation and heavy expenditure by the government on healthcare, followed by Europe and Asia-Pacific. In addition, coated endotracheal tubes providers and distributors have focused on expanding their presence in the emerging economies, which is anticipated to drive the market growth.
A. The total market value of Coated Endotracheal Tube Market is $126.13 million in 2020
A. The forecast period in the report is from 2021 to 2030
A. The market value of Coated Endotracheal Tube Market in 2030 was $237.99 Million
A. The base year for the report is 2020
A. Yes, Coated Endotracheal Tube companies are profiled in the report
A. The top companies that hold the market share in Coated Endotracheal Tube Market are Bactiguard Holding AB, Avanos Medical, Hospiteknik Healthcare, Smiths Medical PLc., Fuji Systems Corp., N8 Medical LLC, Sharklet Technologies, Inc., Medtronic, Teleflex Incorporated and Venner Medical.
A. No, there is no value chain analysis provided in the Coated Endotracheal Tube Market report
A. The key trends in the Coated Endotracheal Tube Market are to prevent or reduce the incidence of hospital acquired infection or ventilator-associated pneumonia (VAP), endotracheal tubes are coated with a drug-releasing coating that releases antimicrobial agents to inhibit bacterial growth and biofilm formation.
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
